Complement 9 in amyloid deposits

References

• Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583–596.
   PubMed Web of Science ®Google Scholar
• Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27(4):217–222.
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27–68.
   PubMed Web of Science ®Google Scholar
• Howie AJ, Brewer DB. Optical properties of amyloid stained by Congo red: history and mechanisms. Micron. 2009;40(3):285–301.
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem. 1962;10(3):355–364.
   Web of Science ®Google Scholar
• Schönland SO, Hegenbart U, Bochtler T, et al. Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood. 2012;119(2):488–493.
   PubMed Web of Science ®Google Scholar
• Brambilla F, Lavatelli F, Di Silvestre D, et al. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood. 2012;119(8):1844–1847.
   PubMed Web of Science ®Google Scholar
• Vrana JA, Gamez JD, Madden BJ, et al. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114(24):4957–4959.
   PubMed Web of Science ®Google Scholar
• Mollee P, Boros S, Loo D, et al. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry. Clin Proteomics. 2016;13:30.
   PubMed Web of Science ®Google Scholar
• Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541(1):163–166.
   PubMed Web of Science ®Google Scholar
• Huang Y, Mahley RW. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis. 2014;72:3–12.
   PubMed Web of Science ®Google Scholar
• Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135(2):235–238.
   PubMed Web of Science ®Google Scholar
• Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apoE to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(17):8098–8102.
   PubMed Web of Science ®Google Scholar
• Müller-Eberhard HJ. Complement. Annu Rev Biochem. 1969;38:389–414.
   PubMed Web of Science ®Google Scholar
• Tegla CA, Cudrici C, Patel S, et al. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol Res. 2011;51(1):45–60.
   PubMed Web of Science ®Google Scholar
• Podack ER, Müller-Eberhard HJ, Horst H, et al. Membrane attack complex of complement (MAC): three-dimensional analysis of MAC-phospholipid vesicle recombinants. J Immunol. 1982;128(5):2353–2357.
   PubMed Web of Science ®Google Scholar
• Esser AF, Kolb WP, Podack ER, et al. Molecular reorganization of lipid bilayers by complement: a possible mechanism for membranolysis. Proc Natl Acad Sci U S A. 1979;76(3):1410–1414.
   PubMed Web of Science ®Google Scholar
• Papadimitriou JC, Drachenberg CB, Shin ML, et al. Ultrastructural studies of complement mediated cell death: a biological reaction model to plasma membrane injury. Virchows Arch. 1994;424(6):677–685.
   PubMed Web of Science ®Google Scholar
• Jenkins CP, Cardona DM, Bowers JN, et al. The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction. Arch Pathol Lab Med. 2010;134(2):256–263.
   PubMed Web of Science ®Google Scholar
• Jasra SK, Badian C, Macri I, et al. Recognition of early myocardial infarction by immunohistochemical staining with cardiac troponin-I and complement C9. J Forensic Sci. 2012;57(6):1595–1600.
   PubMed Web of Science ®Google Scholar
• Pfister F, Vonbrunn E, Ries T, et al. Complement activation in kidneys of patients with COVID-19. Front Immunol. 2020;11:594849.
   PubMed Web of Science ®Google Scholar
• Röcken C, Schwotzer EB, Linke RP, et al. The classification of amyloid deposits in clinicopathological practice. Histopathology. 1996;29(4):325–335.
   PubMed Web of Science ®Google Scholar
• Lavatelli F, Vrana JA. Proteomic typing of amyloid deposits in systemic amyloidoses. Amyloid. 2011;18(4):177–182.
   PubMed Web of Science ®Google Scholar
• UniProt C. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019;47(D1):D506–D515.
   PubMed Web of Science ®Google Scholar
• Team RC. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020.
   Google Scholar
• Wickham H, Averick M, Bryan J, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.
   Google Scholar
• Wickham H. ggplot2: elegant graphics for data analysis (use R!). Cham: Springer; 2016.
   Google Scholar
• Kassambra A. 'ggplot2' based publication ready plots. 0.3.0; 2020.]
   Google Scholar
• D'Souza A, Theis JD, Vrana JA, et al. Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration. Amyloid. 2014;21(2):71–75.
   PubMed Web of Science ®Google Scholar
• Garnier S, Ross N, Rudis B, et al. Default color maps from 'matplotlib'. 0.5.1; 2018.
   Google Scholar
• Sethi S, Theis JD, Vrana JA, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotactoid glomerulopathy. Clin J Am Soc Nephrol. 2013;8(6):915–921.
   PubMed Web of Science ®Google Scholar
• Kourelis TV, Dasari SS, Dispenzieri A, et al. A proteomic atlas of cardiac amyloid plaques. JACC Cardiooncol. 2020;2(4):632–643.
   PubMedGoogle Scholar
• Brambilla F, Lavatelli F, Di Silvestre D, et al. Shotgun protein profile of human adipose tissue and its changes in relation to systemic amyloidoses. J Proteome Res. 2013;12(12):5642–5655.
   PubMed Web of Science ®Google Scholar
• Krance SH, Wu C-Y, Zou Y, et al. The complement cascade in Alzheimer's disease: a systematic review and meta-analysis. Mol Psychiatry. 2019.
   Google Scholar
• Sethi S, Theis JD. Pathology and diagnosis of renal non-AL amyloidosis. J Nephrol. 2018;31(3):343–350.
   PubMed Web of Science ®Google Scholar
• Maleszewski JJ, Murray DL, Dispenzieri A, et al. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2013;22(3):189–194.
   PubMed Web of Science ®Google Scholar
• Michels MAHM, van de Kar NCAJ, Okrój M, et al. Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases. Front Immunol. 2018;9:612.
   PubMed Web of Science ®Google Scholar
• Maga TK, Nishimura CJ, Weaver AE, et al. Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome. Hum Mutat. 2010;31(6):1445–1460.
   PubMed Web of Science ®Google Scholar
• Sethi S, Fervenza FC, Zhang Y, et al. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int. 2012;82(4):465–473.
   PubMed Web of Science ®Google Scholar
• Strassheim D, Renner B, Panzer S, et al. IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol. 2013;24(3):393–406.
   PubMed Web of Science ®Google Scholar
• Huang J, Cui Z, Gu Q-H, et al. Complement activation profile of patients with primary focal segmental glomerulosclerosis. PLoS One. 2020;15(6):e0234934.
   PubMed Web of Science ®Google Scholar
• Thurman JM, Wong M, Renner B, et al. Complement activation in patients with focal segmental glomerulosclerosis. PLoS One. 2015;10(9):e0136558.
   PubMed Web of Science ®Google Scholar
• Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol. 2003;15(6):725–731.
   PubMed Web of Science ®Google Scholar
• Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem. 2002;50(4):449–454.
   PubMed Web of Science ®Google Scholar
• Lundgren DH, Hwang S-I, Wu L, et al. Role of spectral counting in quantitative proteomics. Expert Rev Proteom. 2010;7(1):39–53.
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Doni A, Garlanda C, et al. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157–183.
   PubMed Web of Science ®Google Scholar
• Tacnet-Delorme P, Chevallier S, Arlaud GJ. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions. J Immunol. 2001;167(11):6374–6381.
   PubMed Web of Science ®Google Scholar
• Quist A, Doudevski I, Lin H, et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A. 2005;102(30):10427–10432.
   PubMed Web of Science ®Google Scholar
• Harper JD, Wong SS, Lieber CM, et al. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem Biol. 1997;4(2):119–125.
   PubMedGoogle Scholar
• Hirakura Y, Carreras I, Sipe JD, et al. Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense. Amyloid. 2002;9(1):13–23.
   PubMed Web of Science ®Google Scholar